title: Complementation of alpha-thalassaemia in alpha-globin knockout mice with a 191 kb transgene containing the human alpha-globin locus.
abstract: alpha-thalassaemia is an inherited blood disorder caused by a decrease in the synthesis of alpha-globin due to mutations in one or both of the alpha-globin genes located on human chromosome 16. A 191 kb transgene derived from a sequenced bacterial artificial chromosome (BAC) clone carrying the human alpha-globin gene cluster, together with about 100 kb of sequence upstream of DNase1 hypersensitive site HS-40 and 30 kb downstream of the alpha1-globin gene, was introduced into fertilised mouse oocytes by pronuclear microinjection. Three transgenic founder mice were obtained. Analysis of one transmitting line by fluorescent in situ hybridisation and quantitative PCR demonstrated a single copy integration of the human alpha-globin transgene on chromosome 1. Analysis of haemoglobins from the peripheral blood by cellulose acetate electrophoresis and high performance liquid chromatography (HPLC) demonstrated synthesis of human alpha-globin to about 36% of the level of each mouse alpha-globin locus. Breeding of transgenic mice with mice heterozygous for a knockout (KO) deletion of both murine alpha-globin genes showed that the human alpha-globin locus restored haemoglobin levels and red cell distribution width to normal in double heterozygous mice and significantly normalised other haematological parameters. Interestingly the human transgene also induced a significant increase in red cell production and haematocrit above wild type values. This is the first report demonstrating complementation of a murine alpha-globin KO mutation by human alpha-globin gene expression from an intact human alpha-globin locus. The transgenic mouse model described in this report should be very useful for the study of human alpha-globin gene regulation and for the development of strategies to down regulate alpha-globin production as a means of ameliorating the severity of beta-thalassaemia.
authors.affiliation: CAGT Research Group, The Murdoch Childrens Research Institute, University of Melbourne Department of Paediatrics, Royal Children's Hospital, Flemington Road, Parkville, Victoria 3052, Australia.
authors.forename: Keith
authors.initials: K
authors.lastname: Al-Hasani
authors.forename: Jim
authors.initials: J
authors.lastname: Vadolas
authors.forename: Lucille
authors.initials: L
authors.lastname: Voullaire
authors.forename: Robert
authors.initials: R
authors.lastname: Williamson
authors.forename: Panayiotis A
authors.initials: PA
authors.lastname: Ioannou
mesh_terms: D000818:Animals; D002851:Chromatography, High Pressure Liquid; D022202:Chromosomes, Artificial, Bacterial; D003433:Crosses, Genetic; D017931:DNA Primers; D004195:Disease Models, Animal; D004588:Electrophoresis, Cellulose Acetate; D040461:Gene Components; D005816:Genetic Complementation Test; D005914:Globins / Q000235:genetics* / Q000378:metabolism*; D006400:Hematocrit; D006454:Hemoglobins / Q000737:chemistry; D006801:Humans; D017404:In Situ Hybridization, Fluorescence; D051379:Mice; D018345:Mice, Knockout; D008822:Mice, Transgenic; D008845:Microinjections; D019076:Transgenes / Q000235:genetics; D017085:alpha-Thalassemia / Q000235:genetics*
chemical_list: D017931:DNA Primers; D006454:Hemoglobins; D005914:Globins